Management of Clinically Insignificant Residual Fragments following Shock Wave Lithotripsy

Elisa Cicerello, Franco Merlo, Luigi Maccatrozzo, Elisa Cicerello, Franco Merlo, Luigi Maccatrozzo

Abstract

Clinically insignificant residual fragments (CIRFs) are small fragments (less than 5 mm) that are present in upper urinary tract at the time of regular post-SWL followup. The term is controversial because they may remain silent and asymptomatic or become a risk factor for stone growth and recurrence, leading to symptomatic events, and need further urologic treatment. Although a stone-free state is the desired outcome of surgical treatment of urolithiasis, the authors believe that the presence of noninfected, nonobstructive, asymptomatic residual fragments can be managed metabolically in order to prevent stone growth and recurrence. Further urologic intervention is warranted if clinical indications for stone removal are present.

References

    1. Chaussy C, Brendel W, Schmiedt E. Extracorporeally induced destruction of kidney stones by shock waves. The Lancet. 1980;2(8207):1265–1268.
    1. Balaji KC, Menon M. Mechanism of stone formation. Urologic Clinics of North America. 1997;24(1):1–11.
    1. Drach GW, Dretler S, Fair W. Report of the United States cooperative study of extracorporeal shock wave lithotripsy. Journal of Urology. 1986;135(6):1127–1133.
    1. Candau C, Saussine C, Lang H, Roy C, Faure F, Jacqmin D. Natural history of residual renal stone fragments after ESWL. European Urology. 2000;37(1):18–22.
    1. El-Nahas AR, El-Assmy AM, Madbouly K, Sheir KZ. Predictors of clinical significance of residual fragments after extracorporeal shockwave lithotripsy for renal stones. Journal of Endourology. 2006;20(11):870–874.
    1. Lingeman JE, Newman D, Mertz JHO, et al. Extracorporeal shock wave lithotripsy: the Methodist Hospital of Indiana experience. Journal of Urology. 1986;135(6):1134–1137.
    1. Beck EM, Riehle RA. The fate of residual fragments after extracorporeal shock wave lithotripsy monotherapy of infection stones. Journal of Urology. 1991;145(1):6–10.
    1. Osman MM, Alfano Y, Kamp S, et al. 5-Year-follow-up of patients with clinically insignificant residual fragments after extracorporeal shockwave lithotripsy. European Urology. 2005;47(6):860–864.
    1. Zanetti G, Montanari E, Mandressi A, et al. Long-term results of extracorporeal shock wave lithotripsy in renal stone treatment. Journal of Endourology. 1991;5:61–64.
    1. Delvecchio FC, Preminger GM. Management of residual stones. Urologic Clinics of North America. 2000;27(2):347–354.
    1. Gupta M, Bolton DM, Stoller ML. Etiology and management of cystine lithiasis. Urology. 1995;45(2):344–355.
    1. Klee LW, Brito CG, Lingeman JE. The clinical implications of brushite calculi. Journal of Urology. 1991;145(4):715–718.
    1. Zhong P, Preminger GM. Mechanisms of differing stone fragility in extracorporeal shockwave lithotripsy. Journal of Endourology. 1994;8(4):263–268.
    1. Skolaris A, Mitsogiannis H, Deliveliotis C. Indications, prediction of success and methods to improve outcomes of shock wave lithotripsy of renal and upper ureter calculi. Archivio Italiano di Urologia, Andrologia. 2010;82:56–63.
    1. Demirkesen O, Yaycioglu O, Onal B, et al. Extracorporeal shockwave lithotripsy for stones in abnormal urinary tracts: analysis of results and comparison with normal urinary tracts. Journal of Endourology. 2001;15(7):681–685.
    1. Sheir KZ, Madbouly K, Elsobky E, Abdelkhalek M. Extracorporeal shock wave lithotripsy in anomalous kidneys: 11-Year experience with two second-generation lithotripters. Urology. 2003;62(1):10–15.
    1. Al-Ansari A, As-Sadiq K, Al-Said S, Younis N, Jaleel OA, Shokeir AA. Prognostic factors of success of extracorporeal shock wave lithotripsy (ESWL) in the treatment of renal stones. International Urology and Nephrology. 2006;38(1):63–67.
    1. Symons SJ, Ramachandran A, Kurien A, Baiysha R, Desai MR. Urolithiasis in the horseshoe kidney: a single-centre experience. BJU International. 2008;102(11):1676–1680.
    1. Skolarikos AA, Papatsoris AG, Mitsogiannis IC, Chatzidarellis L, Liakouras C, Deliveliotis C. Current status of ureteroscopic treatment for urolithiasis. International Journal of Urology. 2009;16(9):713–717.
    1. Deliveliotis C, Argiropoulos V, Varkarakis J, Albanis S, Skolarikos A. Extracorporeal shock wave lithotripsy produces a lower stone-free rate in patients with stones and renal cysts. International Journal of Urology. 2002;9(1):11–14.
    1. Montanari E, Zanetti G. Management of urolithiasis in renal transplantation. Archivio Italiano di Urologia e Andrologia. 2009;81(3):175–181.
    1. Challacombe B, Dasgupta P, Tiptaft R, et al. Multimodal management of urolithiasis in renal transplantation. BJU International. 2005;96(3):385–389.
    1. Elbahnasy AM, Shalhav AL, Hoenig DM, et al. Lower caliceal stone clearance after shock wave lithotripsy or ureteroscopy: the impact of lower pole radiographic anatomy. Journal of Urology. 1998;159(3):676–682.
    1. Ghoneim IA, Ziada AM, ElKatib SE. Predictive factors of lower calyceal stone clearance after extracorporeal shockwave lithotripsy (ESWL): a focus on the infundibulopelvic anatomy. European Urology. 2005;48(2):296–302.
    1. Danuser H, Müller R, Descoeudres B, Dobry E, Studer UE. Extracorporeal shock wave lithotripsy of lower calyx calculi: how much is treatment outcome influenced by the anatomy of the collecting system? European Urology. 2007;52(2):539–546.
    1. Madaan S, Joyce AD. Limitations of extracorporeal shock wave lithotripsy. Current Opinion in Urology. 2007;17(2):109–113.
    1. Denstedt JD, Clayman RV, Picus DD. Comparison of endoscopic and radiological residual fragment rate following percutaneous nephrolithotripsy. Journal of Urology. 1991;145(4):703–705.
    1. Jewett MAS, Bombardier C, Caron D, et al. Potential for inter-observer and intra-observer variability in x-ray review to establish stone-free rates after lithotripsy. Journal of Urology. 1992;147(3):559–562.
    1. Baumgartner BR, Steinberg HV, Ambrose SS. Sonographic evaluation of renal stones treated by extracorporeal shock-wave lithotripsy. American Journal of Roentgenology. 1987;149(1):131–135.
    1. Middleton WD, Dodds WJ, Lawson TL, Foley WD. Renal calculi: sensitivity for detection with US. Radiology. 1988;167(1):239–244.
    1. Vieweg J, Teh C, Freed K, et al. Unenhanced helical computerized tomography for the evaluation of patients with acute flank pain. Journal of Urology. 1998;160(3):679–684.
    1. El-Nahas AR, El-Assmy AM, Mansour O, Sheir KZ. A prospective multivariate analysis of factors predicting stone disintegration by extracorporeal shock wave lithotripsy: the value of high-resolution non contrast computed tomography. European Urology. 2007;51(6):1688–1694.
    1. Osman Y, El-Tabey N, Refai H, et al. Detection of residual stones after percutaneous nephrolithotomy: role of noenhanced spiral computerized tomography. Journal of Urology. 2008;179(1):198–200.
    1. Skolaris A, Papatsoris AG. Diagnosis and management of post percutaneous nephrolithotomy residual stone fragments. Journal of Endourology. 2009;23:1751–1755.
    1. Pearle MS, Watamull LM, Mulligan MA. Sensitivity of noncontrast helical computerized tomography and plain film radiography compared to flexible nephroscopy for detecting residual fragments after percutaneous nephrostolithotomy. Journal of Urology. 1999;162(1):23–26.
    1. Carr LK, D’A Honey RJ, Jewett MAS, Ibanez D, Ryan M, Bombardier C. New stone formation: a comparison of extracorporeal shock wave lithotripsy and percutaneous nephrolithotomy. Journal of Urology. 1996;155(5):1565–1567.
    1. Streem SB, Yost A, Mascha E. Clinical implications of clinically insignificant stone fragments after extracorporeal shock wave lithotripsy. Journal of Urology. 1996;155(4):1186–1190.
    1. Khaitan A, Gupta NP, Hemal AK, Dogra PN, Seth A, Aron M. Post-ESWL, clinically insignificant residual stones: reality or myth? Urology. 2002;59(1):20–24.
    1. Zanetti G, Seveso M, Montanari E, et al. Renal stone fragments following shock wave lithotripsy. Journal of Urology. 1997;158(2):352–355.
    1. Bucholz NP, Meier-Padel S, Rutishauser G. Minor residual fragments after shock wave lithotripsy: spontaneous clearance or risk factor for recurrent stone formation? Journal of Endourology. 1997;11:227–232.
    1. Michaels EK, Fowler JE, Mariano M. Bacteriuria following extracorporeal shock wave lithotripsy of infection stones. Journal of Urology. 1988;140(2):254–256.
    1. Cicerello E, Merlo F, Gambaro G, et al. Effect of alkaline citrate therapy on clearance of residual renal stone fragments after extracorporeal shock wave lithotripsy in sterile calcium and infection nephrolithiasis patients. Journal of Urology. 1994;151(1):5–9.
    1. Krings F, Tuerk C, Steinkogler I, Marberger M, Newman DM, Sonda LP. Extracorporeal shock wave lithotripsy retreatment (“stir-up”) promotes discharge of persistent caliceal stone fragments after primary extracorporeal shock wave lithotripsy. Journal of Urology. 1992;148(3):1040–1042.
    1. Moon YT, Kim SC. Fate of clinically insignificant residual fragments after extracorporeal shock wave lithotripsy with EDAP LT-01 lithotripter. Journal of Endourology. 1993;7(6):453–456.
    1. Albanis S, Ather HM, Papatsoris AG, et al. Inversion, hydration and diuresis during extracorporeal shock wave lithotripsy: does it improve the stone-free rate for lower pole stone clearance? Urologia Internationalis. 2009;83(2):211–216.
    1. Preminger GM, Peterson R, Peters PC, Pak CYC. The current role of medical treatment of nephrolithiasis: the impact of improved techniques of stone removal. Journal of Urology. 1985;134(1):6–10.
    1. Preminger GM. The metabolic evaluation of patients with recurrent nephrolithiasis: a review of comprehensive and simplified approaches. Journal of Urology. 1989;141(3):760–763.
    1. Fine JK, Pak CYC, Preminger GM. Effect of medical management and residual fragments on recurrent stone formation following shock wave lithotripsy. Journal of Urology. 1995;153(1):27–33.
    1. Soygur T, Akbay A, Kupely S. Effect of potassium citrate therapy on stone recurrence and residual fragments after shock wave lithotripsy in lower calyceal calcium oxalatae urolithiasis: a randomized controlled trial. Journal of Endourology. 2002;16:149–152.
    1. Sarica K, Erturhan S, Yurtenseven C, et al. Effect of potassium citrate therapy on stone recurrence and regrowth after shock wave lithotripsy in children. Journal of Endourology. 2006;20:875–879.
    1. Lojanapiwat B, Tanthanuch M, Pripathanont C, et al. Alkaline citrate reduces stone recurrence and regrowth after shock wave lithotripsy and percutaneous nephrolithotomy. International Brazilian Journal of Urology. 2011;37:611–616.
    1. Pak CYC. Citrate and renal calculi: an update. Mineral and Electrolyte Metabolism. 1995;20(6):371–377.

Source: PubMed

3
Iratkozz fel